Methods in health service research: An introduction to bayesian methods in health technology assessment

British Medical Journal

Volumn 319, Issue 7208, 1999, Pages 508-512

  Spiegelhalter, David J ^a   Myles, Jonathan P ^a   Jones, David R ^b   Abrams, Keith R ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BAYES THEOREM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEALTH SERVICES RESEARCH; MEDICAL DECISION MAKING; MEDICAL TECHNOLOGY; PHILOSOPHY OF MEDICINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY;

EID: 0033592152     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7208.508     Document Type: Short Survey

References (29)

1. 1 Kadane JB. Prime time for Bayes. Contr Clin Trials 1995;16:313-8.
2. 2 Breslow N. Biostatistics and Bayes. Stat Sci 1990;5:269-84.
3. 3 Lilford RJ, Braunholtz D. The statistical basis of public policy - a paradigm shift is overdue. BMJ 1996;313:603-7.
4. 4 Berry DA, Stangl DK. Bayesian biostatistics. New York: Dekker, 1996.
5. 5 Eddy DM, Hasselblad V, Shachter R. Meta-analysis by the confidence profile method: the statistical synthesis of evidence. San Diego, CA: Academic, 1992.
6. 6 Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine, 2nd ed. Boston: Little Brown, 1991.
7. 7 Pocock S. Spiegelhalter DJ. Domiciliary thrombolysis by general practitioners. BMJ 1992;305:1015.
8. 8 GREAT Group. Feasability, safety and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. BMJ 1992;305:548-53.
9. 9 Cornfield J. Recent methodological contributions to clinical trials. Am J Epidemiol 1976;104:408-21.
10. 10 Lewis RJ, Wears RL. An introduction to the Bayesian analysis of clinical trials. Ann Emergency Med 1993;22:1328-36.
11. 11 Berry DA, Wolff MC, Sack D. Decision-making during a phase-III randomised controlled trial. Contr Clin Trials 1994;15:360-78.
12. 12 Chaloner K, Church T, Louis TA, Matts JP. Graphical elicitation of a prior distribution for a clinical-trial. Statistician 1993;42:341-53.
13. 13 Parmar MKB, Spiegelhalter DJ, Freedman LS. The chart trials: bayesian design and monitoring in practice. Stat Med 1994;13:1297-312.
14. 14 Peto R, Baigent C. Trials: the next 50 years. BMJ 1998;317:1170-1.
15. 15 Spiegelhalter DJ, Freedman LS, Parmar MKB. Bayesian approaches to randomised trials. J Roy Stat Soc Series A 1994;157:357-87.
16. 16 Parmar MKB, Ungerleider RS, Simon R. Assessing whether to perform a confirmatory randomised clinical trial. J Natl Cancer Inst 1996;88:1645-51.
17. 17 Freedman LS, Spiegelhalter DJ, Parmar MKB. The what, why and how of bayesian clinical trials monitoring. Stat Med 1994;13:1371-83.
18. 18 Grossman J, Parmar MKB, Spiegelhalter DJ, Freedman LS. A unified method for monitoring and analysing controlled trials. Stat Med 1994;13:1815-26.
19. 19 Fayers PM, Ashby D, Parmar MKB. Bayesian data monitoring in clinical trials. Stat Med 1997;16:1413-30.
20. 20 Dersimonian R. Meta-analysis in the design and monitoring of clinical trials. Stat Med 1996;15:1237-48.
21. 21 O'Neill R. Early stopping rules workshop: conclusions. Stat Med 1994;13:1493-9.
22. 22 Louis TA. Using empirical Bayes methods in biopharmaceutical research. Stat Med 1991;10:811-29.
23. 23 Dixon DO, Simon R. Bayesian subset analysis in a colorectal cancer clinical trial. Stat Med 1992;11:13-22.
24. 24 Ashby D, Hutton J, McGee M. Simple bayesian analyses for case-control studies in cancer epidemiology. Statistician 1993;42:385-97.
25. 25 Eddy DM, Hasselblad V, Shachter R. An introduction to a bayesian method for meta-analysis - the confidence profile method. Medical Decision Making 1990;10:15-23.
26. 26 Abrams KR, Jones DR. Meta-analysis and the synthesis of evidence. IMA J Math Med Biol 1995;12:297-313.
27. 27 Parmigiani G, Ancukiewicz M, Matchar D. Decision models in clinical recommendations development: the stroke prevention policy model. In: Berry A, Stangl DK, eds. Bayesian biostatistics. New York: Dekker, 1996:207-33.
28. 28 Wolfson LJ, Kadane JD, Small MJ. Expected utility as a policy-making tool: an environmental health example. In: Berry A, Stangl DK, eds. Bayesian biostatistics. New York: Dekker, 1996:261-77.
29. 29 International Conference on Harmonisation. Statistical principles for clincal trials, 1998, www.ich.org/pdfifpma/e9.pdf; accessed May 1999.